Identification of diphenylurea derivatives as novel endocytosis inhibitors that demonstrate broad-spectrum activity against SARS-CoV-2 and influenza A virus both in vitro and in vivo.
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza A virus (IAV) poses enormous challenge in the development of broad-spectrum antivirals that are effective against the existing and emerging viral strains. Virus entry through endocytosis represents an attra...
Main Authors: | Nirmal Kumar, Irshad Maajid Taily, Charandeep Singh, Sahil Kumar, Raju S Rajmani, Debajyoti Chakraborty, Anshul Sharma, Priyanka Singh, Krishan Gopal Thakur, Raghavan Varadarajan, Rajesh P Ringe, Prabal Banerjee, Indranil Banerjee |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-05-01
|
Series: | PLoS Pathogens |
Online Access: | https://doi.org/10.1371/journal.ppat.1011358 |
Similar Items
-
Enhancing Immunogenicity of a Thermostable, Efficacious SARS-CoV-2 Vaccine Formulation through Oligomerization and Adjuvant Choice
by: Mohammad Suhail Khan, et al.
Published: (2023-12-01) -
Neutralizing Efficacy of Encapsulin Nanoparticles against SARS-CoV2 Variants of Concern
by: Sara Khaleeq, et al.
Published: (2023-01-01) -
Phosgene-free synthesis of N-methyl-N′,N′-diphenylurea
by: E.P. van Geest, et al.
Published: (2022-01-01) -
Enhanced protective efficacy of a thermostable RBD-S2 vaccine formulation against SARS-CoV-2 and its variants
by: Nidhi Mittal, et al.
Published: (2023-10-01) -
Synthesis and activity study of novel N,N-diphenylurea derivatives as IDO1 inhibitors
by: Xi-Xi Hou, et al.
Published: (2023-06-01)